<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-6VQOND79</identifier><date>2024</date><creator>Gaberc, Tjaša</creator><creator>Škerl Rifelj, Tjaša</creator><relation>documents/doc/6/URN_NBN_SI_doc-6VQOND79_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-6VQOND79_001.txt</relation><format format_type="issue">3</format><format format_type="type">article</format><format format_type="extent">str. 49-54</format><identifier identifier_type="COBISSID_HOST">208958723</identifier><identifier identifier_type="ISSN">2820-5014</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-6VQOND79</identifier><language>slv</language><publisher publisher_location="Ljubljana">Fakulteta za farmacijo, ŠSSFD</publisher><source>Placebo</source><rights>InC</rights><subject language_type_id="slv">Antibiotiki</subject><subject language_type_id="slv">nevrodegeneracija</subject><subject language_type_id="slv">Nevrodegenerativne bolezni</subject><subject language_type_id="slv">nevroprotekcija</subject><subject language_type_id="slv">nevrovnetje</subject><title>Nevroprotektivno delovanje antibiotikov</title></Record>